Cano Health completes 1-for-100 reverse stock split to regain NYSE compliance

On November 2, 2023, Cano Health, Inc. (“ Cano Health ” or the “ Company ”) issued a press release (the “ Press Release ”) announcing, among other things, that it has filed a Certificate of Amendment (the “ Certificate of Amendment ”) to its Certificate of Incorporation with the Delaware Secretary of State to effect the 1-for-100 reverse stock split (the “ Reverse Stock Split ”) of shares of its Class A and Class B common stock, each previously $0.0001 par value per share (together, the “ Common Stock ”). The Certificate of Amendment became effective immediately upon filing on November 2, 2023 (the “ Effective Time ”).

On November 2, 2023, the Company held a special stockholders’ meeting (the “ Special Meeting ”). At the Special Meeting, the Company’s stockholders approved a proposal to grant the Company’s Board of Directors the discretionary authority to amend the Company’s Certificate of Incorporation to effect a reverse stock split of the authorized shares of the Company’s Common Stock, including both issued and outstanding and unissued shares, at a ratio of 1-for-60, with the Board having the right to adjust such ratio, acting in its sole discretion and in the Company’s best interest, down to 1-for-5 and up to 1-for-100, inclusive, such exact ratio to be determined at any time prior to November 2, 2024 (the “ Reverse Stock Split Proposal ”). A total of 336,931,904 shares of the Company’s Common Stock were present at the Special Meeting in person or by proxy, which represented approximately 62% of the outstanding shares of the Company’s Common Stock as of October 5, 2023, the record date for the S